<DOC>
	<DOCNO>NCT00069615</DOCNO>
	<brief_summary>Devices GlucoWatch G2 Biographer ( GW2B ) , constantly measure blood sugar level , may improve treatment Type 1 diabetes mellitus child . This study evaluate GW2B use child home .</brief_summary>
	<brief_title>Pilot Study GlucoWatch G2 Biographer Management Type 1 Diabetes Children</brief_title>
	<detailed_description>The proper role GW2B management Type 1 diabetes child determine . As prelude large-scale randomized clinical trial ( RCT ) compare effect glycemic control , hypoglycemia , quality life use GW2B versus standard care , DirecNet Study Group conduct pilot study assess feasibility protocol plan RCT collect data change HbA1c , frequency hypoglycemia , frequency skin reaction , quality life use GW2B three month . Fifteen child adolescent Type 1 diabetes participate study . Each patient provide personal computer weekly download GW2B completion questionnaire regard hypoglycemia GW2B use . Participants receive study telephone call 1 , 2 , 4 week every 4 week thereafter review diabetes management . Participants follow-up visit Week 29 . The Continuous Glucose Monitoring System insert visit ass hypoglycemia three day . A follow-up visit perform Week 30 measure HbA1c administer psychosocial questionnaire .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Inclusion Criteria Diagnosis Type 1 diabetes Duration diabetes &gt; 1 year Daily insulin therapy ( pump least 2 injections/day ) Stable insulin regimen ; expect change administration modality within next 3 month ( e.g. , injection user switch pump ) Exclusion Criteria The presence skin abnormality significant medical disorder judgment investigator affect wear sensor completion aspect protocol . Prior use GWB prescribe home use ( Prior use GWB part research study allowable ) The presence follow disease : Asthma treat systemic inhaled corticosteroid last 6 month Cystic fibrosis Other major illness judgment investigator might interfere completion protocol Adequately treat thyroid disease celiac disease exclude Inpatient psychiatric treatment past 6 month either subject subject 's primary care giver ( i.e. , parent guardian ) . Current use oral/inhaled glucocorticoid medication , judgment investigator would contraindication participation study .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetes Mellitus , Insulin-Dependent</keyword>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Continuous Glucose Monitoring Devices</keyword>
	<keyword>Electronic Data Collection</keyword>
</DOC>